- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06782516
Native-RISE (Risk Identification for Suicide and Enhanced Care)
January 29, 2026 updated by: Johns Hopkins Bloomberg School of Public Health
The goal of this research is to test a systems-level suicide prevention strategy, Native-RISE (Risk Identification for Suicide and Enhanced care), that combines predictive analytics and brief contact interventions (BCIs) to reduce suicide in health systems serving Native Americans (NAs).
This project aims to prove the effectiveness and scalability of Native-RISE within three Indian Health Service (IHS) health care clinics (Whiteriver, Chinle and Shiprock) already implementing suicide prevention programs and serving the White Mountain Apache Tribe (WMAT) and Navajo Nation (NN).
Study Overview
Status
Enrolling by invitation
Conditions
Study Type
Interventional
Enrollment (Estimated)
1687
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Chinle, Arizona, United States, 86503
- Chinle Navajo Nation Center for Indigenous Health
-
Whiteriver, Arizona, United States, 85941
- Whiteriver Center for Indigenous Health
-
-
New Mexico
-
Shiprock, New Mexico, United States, 87420
- Shiprock Center for Indigenous Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults aged 18-75
- Visit at least one of the three participating IHS clinics
- Identified as at risk of suicide by either an existing method or the new Native-RISE risk model algorithm
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Case Managers WITH algorithm AND with provider risk notification (SI/SA/Binge/NSSI)
Case Managers who see the algorithm classification + IHS provider risk notification & resource card distribution.
These participants present with suicide ideation (SI), suicide attempt (SA), binge substance use (Binge), or non-suicidal self injury (NSSI).
|
Case managers see the Native-RISE algorithm classification and Clinical Providers receive a risk notification.
A resource card is provided to the participant.
|
|
Active Comparator: Case Managers withOUT algorithm AND with provider risk notification (SI/SA/Binge/NSSI)
Case Managers who do NOT see the algorithm classification + IHS provider risk notification & resource card distribution.
These participants present with suicide ideation (SI), suicide attempt (SA), binge substance use (Binge), or non-suicidal self injury (NSSI).
|
Clinical Providers receive a risk notification and a resource card is provided to the participant.
|
|
Experimental: Case Managers WITH algorithm AND provider risk notification (high risk history, no SI/SA/Binge/NSSI
Case Managers who see the algorithm classification + provider risk notification; participants get resource card distribution.
High risk participants based on algorithm classification.
|
Case managers see the Native-RISE algorithm classification and Clinical Providers receive a risk notification.
A resource card is provided to the participant.
|
|
Active Comparator: Provider risk notification alone (high risk history, without SI/SA/Binge/NSSI)
Provider risk notification alone; participants get resource card distribution.
High risk participants based on algorithm classification.
|
Clinical Providers receive a risk notification and a resource card is provided to the participant.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of suicide attempts among individuals flagged at elevated risk
Time Frame: 12 months
|
Rate of suicide attempts among individuals flagged at elevated risk is tracked through International Classification of Diseases (ICD) codes and chief complaints as recorded in the participating health system.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of contacts with Case Managers (Reach of Brief Contact Interventions (BCI))
Time Frame: 12 months
|
Reach of BCI is defined as at least three or more contacts with Case Managers within the first year following identification of elevated risk.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Emily Haroz, PhD, Johns Hopkins University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Haroz EE, Rebman P, Goklish N, Garcia M, Suttle R, Maggio D, Clattenburg E, Mega J, Adams R. Performance of Machine Learning Suicide Risk Models in an American Indian Population. JAMA Netw Open. 2024 Oct 1;7(10):e2439269. doi: 10.1001/jamanetworkopen.2024.39269.
- Adams R, Haroz EE, Rebman P, Suttle R, Grosvenor L, Bajaj M, Dayal RR, Maggio D, Kettering CL, Goklish N. Developing a suicide risk model for use in the Indian Health Service. Npj Ment Health Res. 2024 Oct 16;3(1):47. doi: 10.1038/s44184-024-00088-5.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2024
Primary Completion (Estimated)
September 30, 2028
Study Completion (Estimated)
December 31, 2028
Study Registration Dates
First Submitted
January 15, 2025
First Submitted That Met QC Criteria
January 15, 2025
First Posted (Actual)
January 20, 2025
Study Record Updates
Last Update Posted (Actual)
February 2, 2026
Last Update Submitted That Met QC Criteria
January 29, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00026145
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide Prevention
-
Mental Health Services in the Capital Region, DenmarkKarolinska InstitutetCompleted
-
University of Sao PauloNot yet recruitingSuicide Ideation | Suicide Attempts
-
University of North Carolina, Chapel HillVillage Heartbeat, Inc.RecruitingSuicide | Suicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
VA Office of Research and DevelopmentNot yet recruiting
-
VA Office of Research and DevelopmentNot yet recruiting
-
George Washington UniversityUniversity of Rochester; Mt. Sinai School of Medicine, New York, New York; American...Recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Not yet recruitingSuicide | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionSpain
-
Yale UniversityNational Institute of Mental Health (NIMH); PossibleRecruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Robert Wood Johnson FoundationRecruitingSuicide | Suicide Attempt | Suicide Ideation | Suicide PreventionUnited States
-
Syeda AYAT E ZAINAB AliUniversity of Leicester; University of WuerzburgRecruitingSuicide, Attempted | Suicide | Suicide Prevention | Completed SuicidePakistan
Clinical Trials on System of Care - combination of algorithm and Brief Contact Intervention
-
Boston Medical CenterNational Institute of Allergy and Infectious Diseases (NIAID); BU Clinical...Completed
-
University of MichiganNational Institute on Drug Abuse (NIDA)CompletedHIV | Substance UseUnited States
-
Emory UniversityCompleted
-
Rhode Island HospitalCompletedAlcohol DrinkingUnited States
-
University of KonstanzJimma UniversityCompleted
-
New York UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHepatitis C | Human Immunodeficiency Virus | Alcohol AbuseUnited States, Russian Federation
-
Peking Union Medical College HospitalCompleted
-
Johns Hopkins Bloomberg School of Public HealthMuhimbili University of Health and Allied SciencesCompleted
-
Evelyn Vanina ReNot yet recruitingEssential HypertensionArgentina
-
VA Office of Research and DevelopmentCompletedAlcohol ConsumptionUnited States